Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10975388
Methods and compositions for nucleic acid and protein payload delivery
granted -
US 10973830
Substituted quinoxaline DNA-PK inhibitors
granted -
US 10975064
RIP1 inhibitory compounds and methods for making and using the same
granted -
CN 112638413
Oral immunotherapy unit dose dispensing systems and methods
granted -
WO 2021064188
COMBINAISON COMPRENANT UN INHIBITEUR DE HDAC, UN INHIBITEUR DE CTLA-4 ET UN INHIBITEUR DE PD-1 OU UN INHIBITEUR DE PD-L1 POUR LE TRAITEMENT DU CANCER
granted -
US 10968495
Lactobacillus reuteri and use thereof
granted -
US 10967063
Surfactant-free, water-free formable composition and breakable foams and their uses
granted -
US 10968205
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10968249
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 10967016
Traditional Chinese medicine composition and use thereof
granted -
US 10966931
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
granted -
US 10967050
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10966970
Fused tricyclic compounds and uses thereof in medicine
granted -
US 10967051
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
granted -
US 10968442
Chimeric clotting factors
granted -
US 10968261
Methods and compositions for genome engineering
granted -
US 10968278
Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
granted -
US 10968248
Trinucleotide mRNA cap analogs
granted -
US 10968452
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof
granted -
US 10968231
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders
granted -
US 10968222
2-azabicyclo hexane JAK inhibitor compound
granted -
US 10968213
Cyclopropanamine compound and use thereof
granted -
US 10968201
Bicyclic carboxamides and methods of use thereof
granted -
US 10968206
Cannabinergic nitrate esters and related analogs
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.